Risk factors for acute kidney injury during aminoglycoside therapy in patients with cystic fibrosis

Kevin J. Downes,Neha R. Patil,Marepalli B. Rao,Rajesh Koralkar,William T. Harris,John P. Clancy,Stuart L. Goldstein,David J. Askenazi

Risk factors for acute kidney injury during aminoglycoside therapy in patients with cystic fibrosis

2015

Kevin J. Downes
Neha R. Patil
Marepalli B. Rao
Rajesh Koralkar
William T. Harris
John P. Clancy
Stuart L. Goldstein
David J. Askenazi

Background Aminoglycoside (AG) therapy is a common cause of acute kidney injury (AKI) in cystic fibrosis (CF) patients. The aim of this study was to identify factors associated with AKI during intravenous AG courses in this population.

Keywords:

Aminoglycoside
Cystic fibrosis
Acute kidney injury
Young adult
Intensive care medicine
Retrospective cohort study
Population
Diabetes mellitus
Medicine
Antibiotics
Endocrinology
Internal medicine
Gastroenterology
Nephrology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations